Enhanced levels of prostaglandin E2 and matrix metalloproteinase‐2 correlate with the severity of airflow limitation in stable COPD
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background and objective: Cyclooxygenase‐2 (COX‐2) and its product prostaglandin E 2 (PGE 2) have been demonstrated to play critical roles in inflammation in respiratory diseases. However, the role of COX‐2 in airway remodelling in COPD remains to be elucidated. Matrix metalloproteinase‐2 (MMP‐2) is associated with both inflammation and airway remodelling in COPD. The objective of this study was to measure the expression of COX‐2 and the concentrations of PGE 2 and MMP‐2, and to investigate the role of COX‐2 and PGE 2 in airflow limitation mediated by MMP‐2, in the pathogenesis of COPD. Methods: Forty‐three patients with stable COPD, twelve smoking control subjects and ten non‐smoking control subjects were enrolled. Induced sputum was obtained for measurement of the concentrations of PGE 2 and MMP‐2 by ELISA. COX‐2 protein expression was assessed by western blotting. Results: PGE 2 and MMP‐2 concentrations were significantly higher in both smoking control subjects and patients with COPD than in non‐smoking control subjects (P < 0.01). Moreover, the levels of PGE 2 and MMP‐2 were inversely correlated with FEV 1% predicted in COPD patients (PGE 2: r = −0.748, P < 0.01; MMP‐2: r = −0.801, P < 0.01). Levels of PGE 2 were also positively correlated with those of MMP‐2 in patients with COPD (r = 0.775, P < 0.01). Expression of COX‐2 protein was significantly higher in COPD patients than in non‐smoking control subjects. Conclusions: COX‐2 and its product PGE 2 are not only involved in airway inflammation, but may also contribute to the severity of airflow limitation mediated by MMP‐2 during progression of COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Cited by
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Adcock, I. M., Caramori, G., & Barnes, P. J. (2011) · Respiration · doi:10.1159/000324601 · Cited by 257
“The role of the CXCR4/CXCL12 axis and of hnRNP A2/B1 in the pathogenesis of COPD and in the associated lung carcinogenesis should be explored. Prostaglandins in COPD and Lung CancerThe enzyme COX-2 and its product PGE 2 may enhance the inflammatory response as well as carcinogenesis through effects on cell proliferati…”
Bozinovski, S., Uddin, M., Vlahos, R., Thompson, M., McQualter, J. L., Merritt, A.-S., Wark, P. A. B., Hutchinson, A., Irving, L. B., Levy, B. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109382109 · Cited by 163
“Bronchial cell injury induces ALX/FPR2 epithelial expression, in part, via prostaglandin E2 (PGE2) (13) and the staining pattern in COPD airways is consistent with increased PGE2 levels observed in COPD airways (26).”
BackgroundDagouassat, M., Gagliolo, J.-M., Chrusciel, S., Bourin, M.-C., Duprez, C., Caramelle, P., Boyer, L., Hue, S., Stern, J.-B., Validire, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1361oc · Cited by 120
“PGE2 is the major eicosanoid product of fibroblasts (13), and is overproduced and secreted by COPD fibroblasts (10, 14).”
BackgroundResultUnravelling the Complexity of COPD by MicroRNAs: It’s a Small World after All
Osei, E. T., Florez-Sampedro, L., Timens, W., Postma, D. S., Heijink, I. H., & Brandsma, C.-A. (2015) · European Respiratory Journal · doi:10.1183/13993003.02139-2014 · Cited by 80
Metadata
- Authors
- CHEN, Y., CHEN, P., HANAOKA, M., DROMA, Y., & KUBO, K.
- Venue
- Respirology
- Publisher
- Wiley
- Published
- 2008-10-22
- Volume
- 13
- Issue
- 7
- Pages
- 1014-1021
- ISSN
- 1323-7799 (ISSN-L)
- 1440-1843
- OpenAlex
- W1972110742
- Cited by
- 105
- References
- 3
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced levels of prostaglandin E2 and matrix metalloproteinase‐2 correlate with the severity of airflow limitation in stable COPD. https://app.cochat.ai/papers/10.1111/j.1440-1843.2008.01365.x
- The paper
- CHEN, Y., CHEN, P., HANAOKA, M., DROMA, Y., & KUBO, K. (2008). Enhanced levels of prostaglandin E2 and matrix metalloproteinase‐2 correlate with the severity of airflow limitation in stable COPD. Respirology. https://doi.org/10.1111/j.1440-1843.2008.01365.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.